About
What We Do?
Ventis Pharma Corporation is a biopharmaceutical company focused on developing and Formulating innovative pain management therapies. We create solutions to treat patients with a variety of post-operative pain and pain syndromes.
We develop safe, effective, and suitable therapies for a wide variety of patient applications that serve both adults and children.
We currently hold multiple patents, or have patents pending, in the US and 40 other countries for our long-acting, low-toxicity local anesthetic formulation, Enduracaine™. At Ventis Pharma, we conduct ongoing research and development activities for adjuvant agents to prolong pain relief interventions in a wide variety of patient care situations.
Quite simply, our company focuses on developing innovative pain management solutions for medical professionals and their patients.
![](https://ventispharma.com/wp-content/uploads/2023/06/concentrated-doctor-working-with-virtual-screen-min-1024x683.jpg)
![](https://ventispharma.com/wp-content/uploads/2023/11/iStock-593305048-1-1024x683.jpg)
Ventis' Vision
To significantly improve patient care by providing safe, low-toxicity, and cost-effective solutions that eliminate the need for perioperative narcotics.
Ventis’ Mission
Ventis Pharma Corporation strives to become a world leader in advancing pain management solutions. Our innovative, long-acting, low-toxicity Formulations are designed to reduce surgical pain and treat chronic pain conditions safely and effectively. By making our Formulations cost-effective and available throughout the world, we can improve the quality of life for all patients